Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301379 · ClinicalTrials.gov registry record
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 59
- Enrollment target
NCT00301379 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 59 participants.
The verdict
NCT00301379 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This is an observational study intended to validate results of a previous study done at the Mayo Clinic. Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant. A staging laparotomy is performed before chemoradiation in order to identify patients who will most benefit from the treatment and to improve outcomes.
Interventions
- OTHER Observation data collection study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2005-08-12 |
| Est. Completion | 2023-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00301379
The ClinicalTrials.gov registry entry for NCT00301379 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation data collection study. is the first listed.
NCT00301379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00301379 about?
NCT00301379 is a clinical study titled "Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients". This is an observational study intended to validate results of a previous study done at the Mayo Clinic. Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant. A staging laparotomy is performed before chemoradiation in ...
What is the current status of trial NCT00301379?
This trial is currently terminated. The enrollment target is 59 participants. The study started on 2005-08-12. Estimated completion is 2023-06-06.
What interventions are being tested in trial NCT00301379?
The interventions under investigation include: Observation data collection study. (OTHER).
Who is sponsoring clinical trial NCT00301379?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.